Workshop on 'Advances in targeted radionuclide therapy', Nantes, France

An international workshop on 'Advances in targeted radionuclide therapy' will be held in Nantes, France, on 25 and 26 May. The event is organised by the EU-funded TARCC ('Targeting alpha-radionuclides to combat cancer') project, in collaboration with Targeted RadioNuclide Therapy (TRNT) and the Tumor Targeting Network (TTN) of Cancéropôle Grand Ouest.

This first edition of the workshop will cover the latest advances in targeted radionuclide therapy research, with both alpha-emitting and beta-emitting radionuclides. Five main topics are on the agenda:
- radionuclides and radionuclide chemistry;
- innovative vectors for targeted radionuclide therapy;
- targeted radionuclide therapy of haematological diseases;
- new targets for solid tumour radionuclide therapy;
- dosimetry in targeted radionuclide therapy and radiobiology.

The workshop is open to partners of TARCC, TRNT and TTN, as well as all students, clinicians and scientists involved in targeted radionuclide therapy research who are willing to share their experiences via an oral or poster presentation.For further information, please click:
http://www.tarcc.org./index.php?option=com_content&task=view&id=63&Itemid=70 (here)